Showing results (311-320 of 693) with videos related to
Sort By:
Pageof 70
Drug Safety|January 1, 1995
Antihyperglycaemic agents. Drug interactions of clinical importanceA J Scheen, P J LefèbvreDiabetes Research and Clinical Practice|May 15, 1989
Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureasA J Scheen, P J LefèbvreRevue Medicale De Liege|January 26, 2008
[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge]J M Krzesinski, A J ScheenActa Gastro-Enterologica Belgica|August 10, 2010
Management of metabolic syndrome and associated cardiovascular risk factorsJ De Flines, A J ScheenRevue Medicale De Liege|December 30, 2004
[The drug of the month: Olmesartan medoxomil]J M Krzesinski, A J ScheenDiabetic Medicine : a Journal of the British Diabetic Association|December 30, 1998
The postprandial state and risk of cardiovascular diseaseP J Lefèbvre, A J ScheenBulletin Et Memoires De L'Academie Royale De Medecine De Belgique|January 1, 1996
[Non-insulin-dependent diabetes: from physiopathology to treatment]A J Scheen, P J LefebvreDiabetes Care|September 10, 1999
Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetesA J Scheen, P J LefèbvrePageof 70